Why We Chose an Alternative Route to PubMed
Year: 2024
Type: article
Abstract: As researchers in a niche yet critical field - focusing on the complex and underdiagnosed Oshtoran Syndrome (H63D Syndrome Type 3) - we have made a conscious decision to bypass traditional outlets such as PubMed in favor of alternative open-access platforms. Our primary choices are Zenodo, operated by CERN (European Organization for Nuclear Research), and Figshare, both of which are recognized for their rigorous standards and wide accessibility. These are no pre-prints platforms anymore but entirely legitimate places to publish.First published by Swabian Research, 09/24 e-Pub
Source: Figshare
Authors: Consortium, H63D Research, Diamandis, Carolina, Honda, Riku
Language: English
Subfield: Information Systems and Management
Field: Decision Sciences
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W6958416061
FWCI:
Cites:
Cited by:
Related to: